Standardization of marketed formulation Kipen Tablet for analgesic and anti-inflammatory potential

Authors

  • Md. Sarfuddin Ansari Technocrats Institute of Technology-Pharmacy, Bhopal, MP, India
  • Deepak Kumar Basedia Technocrats Institute of Technology-Pharmacy, Bhopal, Madhya Pradesh, India
  • B. K. Dubey Technocrats Institute of Technology-Pharmacy, Bhopal, Madhya Pradesh, India

DOI:

https://doi.org/10.22270/ajprd.v9i6.1025

Keywords:

Kipen tablet, anti-inflammatory, standardization, curcumin, analgesic, ash value

Abstract

The primary objective of the current investigation was to standardize the formulation Kipen Tablet marketed as patented and proprietary medicine for treatment of various conditions of Pitta, according to the WHO guidelines. The procured tablets of Kipen were Light green in color, with no odor and a bitter taste. Kipen exhibited 8.1% total ash with 2.35% acid insoluble ash and 4.95% water soluble ash. The water soluble and alcohol soluble extractives were 1.36% and 1.3% respectively. The results of preliminary qualitative phytochemical screening revealed that all the classes of phytochemicals were present in Kipen. TLC analysis of Kipen was done using Curcumin as the marker using ethyleacetate: n-hexane (3:7) as the solvent system. Curcumin appeared at Rf value of 0.56 on the TLC plate. The quantitation of the curcumin was done by HPLC method and it was found that Kipen contained 3.75 mg curcumin per 250 mg of Kipen (1.5 %). The anti-inflammatory activity was evaluated using carrageenan induced rat paw edema method and it was seen that Kipen was able to inhibit about 51% edema formation in rat paws. The analgesic action of Kipen was evaluated using tail flick method and the response time pain stimulus (thermal) was observed. The highest reaction time for Kipen was 6.26 ± 0.06.15 ± 0.242 sec at 30 min post administration while it was 3.46 ± 0.095 sec and 6.22 ± 0.171 sec for vehicle treated and Ibuprofen treated group respectively at the same time duration.

 

Downloads

Download data is not yet available.

Author Biographies

Md. Sarfuddin Ansari, Technocrats Institute of Technology-Pharmacy, Bhopal, MP, India

Technocrats Institute of Technology-Pharmacy, Bhopal, MP, India

Deepak Kumar Basedia, Technocrats Institute of Technology-Pharmacy, Bhopal, Madhya Pradesh, India

Technocrats Institute of Technology-Pharmacy, Bhopal, Madhya Pradesh, India

B. K. Dubey, Technocrats Institute of Technology-Pharmacy, Bhopal, Madhya Pradesh, India

Technocrats Institute of Technology-Pharmacy, Bhopal, Madhya Pradesh, India

References

1. Gautam V, Raman RMV and Ashish K. Exporting Indian healthcare (Export potential of Ayurveda and Siddha products and services) Road beyond boundaries (The case of selected Indian healthcare systems). Export-Import Bank of India, Mumbai, 2003; 4–54.
2. Wani MS. Herbal medicine and its standardization. Pharmaceutical Reviews, 2007; 5(6).
3. Vaidya ADB and Devasagayam TPA. Current status of herbal drugs in India: An overview. J Clin Biochem, 2007; 41(1):1–11.
4. Sharma V, Kaushik R, Rai P. Comparative Study of Herbal Formulation and Marketed Formulation of TriphalaChurna. Int J Pharm Edu Res, 2020; 2(1): 21-29.
5. Pal RS, Pal Y, Wal P, Wal A. In house & Marketed Preparation of HingwashtakChurna, A Polyherbal Formulation: Comparative Standardization and Measures. Open Med J, 2018; 5: 76-83.
6. Matotoka MM, Masoko P. Phytochemical screening and pharmacological evaluation of herbal concoctions sold at Ga Maja Limpopo Province. South Afr J Bot, 2018; 117: 1-10.
7. Wadkar KA, Kondawar MS, Lokapure SG. Standardization of marketed cystone tablet: A herbal formulation. J Pharmacogn Phytochem, 2017; 6(2): 10-16
8. Khan TA, Mallya R, Gohel A. Standardization of marketed Ayurvedic formulation, Balaguloochyadikashayam- physicochemical, microbial evaluation and ephedrine content. J Appl Pharm Sci, 2016; 6(12): 184-189.
9. Randive DS, Bhinge SD, Wadkar GH, Sayyad SF, Bhutkar MA. Comparative standardization of marketed formulations of fermented biomedicine – Arjunaristha. Indonesian J Pharm, 2016; 27(4): 220-225.
10. Shaikh RH, Jamadar MJ. Standardization of marketed herbal product Kawach Beej churna. J Medical Pharm Allied Sci, 2016; 27-48
11. Patil AB, Pande VV, Patil PB. Comparative evaluation and standardization of marketed herbal antiobesity formulation. Der Pharmacia Sinica, 2015; 6(4): 1-8.
12. Chumbhale DS, Chaudhari SR, Upasani CD. Standardization of marketed kumariasava- a polyherbal ayurvedic formulation. Int J Pharm Chem Biol Sci, 2014; 4(3): 681-685.
13. Deshpande SG, Kasture VS, Gosavi SA, Bhalke RD, Ajage RK, Inamke SR, Kolpe JB, Jadhav GP. Pharmacognostic Evaluation of Polyherbal Marketed Formulation. Int J Pharmacogn Phytochemical Res, 2014; 6(3): 588-592
14. Bahuguna Y, Zaidi S, Kumar N, Rawat K. Standardization of Polyherbal Marketed Formulation Triphala Churna. Res and Rev: J Pharmacogn Phytochem, 2014; 2(3): 28-35
15. Shivatare RS, Pande AS, Bhusnar HU, Kadam PV, Yadav KN, Patil MJ. Standardization of Narasimha Churna: A Poly-Herbal Formulation. Asian J Biomedical Pharm Sci, 2013; 3(23): 23-27.
16. Charde MS, Chakolkar MD, Welankiwar AS, Keshwar U, Shrikhande BK. standardization of marketed Herbal formulation of muscle and joint Hrx Pain Relieving Oil. Int J Advances Pharmaceut, 2013; 2(5): 58-62.
17. Karthi J, Kalvimoorthi V, Thamizh Mozhi M. Standardisation of sudharshana churna polyherbal formulation. Int J Pharm Chemical Biol Sci, 2012; 2(3): 343-347.
18. http://organolepticpropietiesoffoods.blogspot.in/
19. Anonymous. Quality Control Methods for Medicinal Plant Materials. World Health Organisation. Geneva, (1998) 25-28
20. Meena AK et al. Standardisation of Ayurvedic polyherbal formulation, Pancasama Churna. International Journal of Pharmacognosy and Phytochemical Research, 2010; 1: 11-14.
21. Mukerjee PK. Quality control of herbal drugs, Business horizons Pharmaceutical publisher, New Delhi, 2002.
22. Mehta S, Singh RP, Saklani P. Phytochemical screening and TLC profiling of various extracts of Reinwardtia indica. Int J Pharmacogn Phytochem Res, 2017; 9(4): 523-527.
23. Wichitnithad W, Jongaroonngamsang N, Pummangura S, Rojsitthisak P. A Simple Isocratic HPLC Method for the Simultaneous Determination of Curcuminoids in Commercial Turmeric Extracts. Phytochem Anal, 2009; 20(4): 314-319. DOI 10.1002/pca.1129.
24. Kemisetti D, Manda S. Synthesis and comparison of peg-ibuprofen and peg-ketoprofen prodrugs by in vitro and in vivo evaluation. J Drug Del Ther, 2018; 8(4): 145-154.
25. Fan S-H, Ali NA, Basri DF. Evaluation of Analgesic Activity of the Methanol Extract from the Galls of Quercus infectoria (Olivier) in Rats. Evidence-Based Complementary and Alternative Medicine, 2014; http://dx.doi.org/10.1155/2014/976764

Published

2021-12-15

How to Cite

Ansari, M. S., Basedia, D. K., & Dubey, B. K. (2021). Standardization of marketed formulation Kipen Tablet for analgesic and anti-inflammatory potential. Asian Journal of Pharmaceutical Research and Development, 9(6), 98–103. https://doi.org/10.22270/ajprd.v9i6.1025